Literature DB >> 10603043

Docetaxel neuropathy: a distal axonopathy.

R Fazio1, A Quattrini, A Bolognesi, G Bordogna, E Villa, S Previtali, N Canal, R Nemni.   

Abstract

Docetaxel has been implicated as a causative agent in peripheral neuropathy, but pathological changes in peripheral nerve have not been described. During docetaxel treatment a 54-year-old man developed a sensorimotor polyneuropathy when the overall docetaxel dosage was 540 mg/m(2). Neurophysiological investigation revealed a sensorimotor axonal neuropathy. Fascicular sural nerve biopsy showed an axonal neuropathy with a preferentially loss of large myelinated fibers. There was evidence of considerable fiber regeneration. Sensory and motor symptoms progressively improved after docetaxel withdrawal.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10603043     DOI: 10.1007/s004010051132

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  7 in total

1.  Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat.

Authors:  W H Xiao; H Zheng; F Y Zheng; R Nuydens; T F Meert; G J Bennett
Journal:  Neuroscience       Date:  2011-10-19       Impact factor: 3.590

2.  Paraneoplastic necrotizing myopathy in a woman with breast cancer: a case report.

Authors:  Joana Silvestre; Luis Santos; Vitor Batalha; Ana Del Rio; Carlos Lima; Antonio Carvalho; Ana Martins; Helena Miranda; Fatima Cabral; Adelia Felix; Ana Aleixo
Journal:  J Med Case Rep       Date:  2009-11-02

3.  An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat.

Authors:  Christopher M Peters; Juan Miguel Jimenez-Andrade; Michael A Kuskowski; Joseph R Ghilardi; Patrick W Mantyh
Journal:  Brain Res       Date:  2007-07-17       Impact factor: 3.252

4.  Proteome and Network Analysis Provides Novel Insights Into Developing and Established Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Larissa de Clauser; Christin Kappert; Julia R Sondermann; David Gomez-Varela; Sarah J L Flatters; Manuela Schmidt
Journal:  Front Pharmacol       Date:  2022-02-18       Impact factor: 5.810

5.  Nail alterations as a surrogate marker for the efficacy of low-dose metronomic chemotherapy.

Authors:  Kayoko Kibata; Takeshi Tamaki; Noriko Inagaki; Makoto Ogata; Toshiki Shimizu; Shosaku Nomura
Journal:  Oncol Lett       Date:  2013-02-05       Impact factor: 2.967

6.  Neurosteroid 3α-androstanediol efficiently counteracts paclitaxel-induced peripheral neuropathy and painful symptoms.

Authors:  Laurence Meyer; Christine Patte-Mensah; Omar Taleb; Ayikoe Guy Mensah-Nyagan
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

Review 7.  Taxane-Induced Peripheral Neurotoxicity.

Authors:  Roser Velasco; Jordi Bruna
Journal:  Toxics       Date:  2015-04-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.